Markets open

JNJ Johnson & Johnson

Healthcare · Close of 19 Nov 26

$267.14 -2.04%

⭐ Log in to follow stocks and set price alerts (free) Log in

24 Aug 2026SMA5019 Nov 2026
1 month+3.63%
3 months-1.15%
Year to date+29.08%
1 year+33.57%
52-week range$199.38 – $290.25
SMA50 / SMA200$267.33 / $250.66
RSI 1445
Avg daily move (ATR)2.6%
TrendMixed

Financials (from SEC filings)

📅 Next earnings: 20 Jan 2027 · date estimated from last year

Revenue (TTM)$99.3B
Net income (TTM)$16.1B
EPS (TTM)$6.58
P/E (price ÷ EPS)40.6
Market cap$643B
Net margin16.2%

What changed in the latest quarter (Q3 2026)

Johnson & Johnson (JNJ) – Q3 2026 (ended Sep 27, 2026)

  • Revenue: $25.4B, up 5.9% from the same quarter a year earlier
  • Gross margin: 68.1%, slightly down from 69.6% a year ago
  • Net income: only $210M, down 95.9% from a year ago (earlier quarters were around $5B)
  • Net margin: 0.8% vs 21.5% a year ago
  • EPS (earnings per share): $0.09, down 95.8%
  • Operating margin: not available in this data
  • Balance sheet: cash of $16.9B vs long-term debt of $35.8B

In simple terms: sales kept growing, but net profit fell sharply this quarter. The data does not say why. These are reported quarterly figures, not derived from the annual report.

QuarterRevenueNet incomeEPSNet margin
Q3 2026ended 27 Sept 2026 $25.4B+5.9% YoY $210M-95.9% YoY $0.09-95.8% YoY 0.8%
Q2 2026ended 28 Jun 2026 $25.3B+6.6% YoY $5.5B-0.1% YoY $2.27-0.9% YoY 21.9%
Q1 2026ended 29 Mar 2026 $24.1B+9.9% YoY $5.2B-52.4% YoY $2.14-52.9% YoY 21.8%
Q4 2025*ended 28 Dec 2025 $24.6B+9.1% YoY $5.1B+49.1% YoY $2.08+47.5% YoY 20.8%
Q3 2025ended 28 Sept 2025 $24.0B+6.8% YoY $5.2B+91.2% YoY $2.12+91.0% YoY 21.5%
Q2 2025ended 29 Jun 2025 $23.7B+5.8% YoY $5.5B+18.2% YoY $2.29+18.7% YoY 23.3%

YoY = vs the same quarter a year earlier · quarters follow the company's fiscal year * Q4 = full year minus the first three quarters (EPS approximate)

Balance sheet as of 2026-09-27: Cash $16.9B · Long-term debt $35.8B · Equity $81.5B

Numbers from SEC EDGAR (the company's 10-Q/10-K filings), updated daily · AI summary from the numbers only, not investment advice ·Open the 10-Q filed 2026-10-21

🏛 US Congress trades in this stock (12 months)

Reports can arrive up to 45 days after the trade and give amount ranges only. By the time you see this, the trade is old news: no inside information, not a trading signal.

FiledMemberAsset Type Amount (range) Traded
30 Oct 26PDFThomas H. Kean JrNJ07 · selfJNJJohnson & Johnson Common Stock Partial sell $1,001 - $15,000 30 Sept 2630 days later
5 Oct 26PDFLloyd DoggettTX37 · selfJNJJohnson & Johnson Common Stock Buy $1,001 - $15,000 8 Sept 2627 days later
12 Sept 26PDFThomas H. Kean JrNJ07 · selfJNJJohnson & Johnson Common Stock (JNJ) [ST] (Subholding of: State Street Bank & Trust Co.) Partial sell $1,001 - $15,000 27 Aug 2616 days later
14 Aug 26PDFRichard Dean Dr McCormickGA06 · selfJNJJohnson & Johnson Common Stock Sell $1,001 - $15,000 30 Jul 2615 days later

See all trades

Today's AI analysis

The AI is analysing this stock. Refresh in a moment.

For education only, not a recommendation to buy or sell. Investing involves risk.